News

The ICDS has been the largest global meeting for healthcare professionals and researchers working in the field of coeliac disease and other gluten-related disorders for over 40 years. This year the event will be hosted by the Royal Hallamshire Gastroenterology Team, Sheffield.

Dr Schar are delighted to offer 4 lucky dietitians the opportunity to win a travel, accommodation and registration bursary to attend the International Coeliac Disease Symposium (ICDS) 2024.

The American Gastroenterological Association has recognised UK IBS research within it’s list of top 20 high-impact clinical research articles of 2022.

In the absence of any pragmatic head-to-head trials comparing the LFD, GFD and TDA for the management of IBS, this randomised trial sought to investigate the efficacy, acceptability, nutritional and stool microbial changes associated with these diets.

This document outlines Dr Schar's commitment to product quality, safety & the health of our consumers and planet.

The aim of this study was to assess the efficacy of the low FODMAP diet at long-term follow-up, assess changes to nutritional and FODMAP composition at long-term follow-up in addition to effect on socialising.

The aim of this UK multicentre study was to assess the degree of delay present in the diagnostic referral pathway for CD as well as determine concordance with biopsy guidelines along with attitudes towards CD in an attempt to characterise reasons for delay.

This study aimed to assess the efficacy and acceptability of a short-term strict LFD and long-term ‘modified’ FODMAP diet in patients with diarrhoea-predominant IBS (IBS-D) in India.

This prospective controlled study aimed to evaluate the effect of a telephone clinic and accompanying leaflet on GFD knowledge and GF dietary adherence in adults with CD.